Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma.
Saved in:
| Title: | Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. |
|---|---|
| Authors: | Watson, Zachary L.1 (AUTHOR), Yamamoto, Tomomi M.1 (AUTHOR), McMellen, Alexandra2 (AUTHOR), Kim, Hyunmin3 (AUTHOR), Hughes, Connor J.4 (AUTHOR), Wheeler, Lindsay J.5 (AUTHOR), Post, Miriam D.1,6 (AUTHOR), Behbakht, Kian1,5 (AUTHOR), Bitler, Benjamin G.1 (AUTHOR) benjamin.bitler@ucdenver.edu |
| Source: | Clinical Epigenetics. 11/27/2019, Vol. 11 Issue 1, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 139882395 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Watson%2C+Zachary+L%2E%22">Watson, Zachary L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Yamamoto%2C+Tomomi+M%2E%22">Yamamoto, Tomomi M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22McMellen%2C+Alexandra%22">McMellen, Alexandra</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kim%2C+Hyunmin%22">Kim, Hyunmin</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hughes%2C+Connor+J%2E%22">Hughes, Connor J.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wheeler%2C+Lindsay+J%2E%22">Wheeler, Lindsay J.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Post%2C+Miriam+D%2E%22">Post, Miriam D.</searchLink><relatesTo>1,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Behbakht%2C+Kian%22">Behbakht, Kian</searchLink><relatesTo>1,5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bitler%2C+Benjamin+G%2E%22">Bitler, Benjamin G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> benjamin.bitler@ucdenver.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Clinical+Epigenetics%22">Clinical Epigenetics</searchLink>. 11/27/2019, Vol. 11 Issue 1, pN.PAG-N.PAG. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=139882395 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s13148-019-0758-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: Histone methyltransferases EHMT1 and EHMT2 (GLP/G9A) maintain PARP inhibitor resistance in high-grade serous ovarian carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Watson, Zachary L. – PersonEntity: Name: NameFull: Yamamoto, Tomomi M. – PersonEntity: Name: NameFull: McMellen, Alexandra – PersonEntity: Name: NameFull: Kim, Hyunmin – PersonEntity: Name: NameFull: Hughes, Connor J. – PersonEntity: Name: NameFull: Wheeler, Lindsay J. – PersonEntity: Name: NameFull: Post, Miriam D. – PersonEntity: Name: NameFull: Behbakht, Kian – PersonEntity: Name: NameFull: Bitler, Benjamin G. IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 11 Text: 11/27/2019 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 18687075 Numbering: – Type: volume Value: 11 – Type: issue Value: 1 Titles: – TitleFull: Clinical Epigenetics Type: main |
| ResultId | 1 |